Institutional investors purchased a net $3.8 million shares of PCYC during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 71.44% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
QUANTBOT TECHNOLOGIES LLC Bought 7.9 Thousand shares of Pharmacyclics Inc
RIEDWEG & HROVAT AG Bought 7.5 Thousand shares of Pharmacyclics Inc